Clinical trials show partial meal replacement products to be safe, acceptable and effective when used as part of an overall low-energy diet
Overweight (body mass index [BMI] > 25 kg/m2) and obesity (BMI > 30 kg/m2) are now major health concerns, being causally related to a number of metabolic disorders, and affecting at least one in two adult Australians.1 However, the long-term evidence on treatment of these conditions is disappointing. A strategy recommended in the recent clinical guidelines from the National Health and Medical Research Council is the use of low-energy meal replacement products.1 These have been marketed for many years, but have only recently been considered seriously in large clinical trials. If effective, this strategy offers promise as:
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. National Health and Medical Research Council. National clinical guidelines for weight control and obesity management. Canberra: Commonwealth Department of Health and Ageing, 2002.
- 2. Food Standards Australia New Zealand. Australia New Zealand food standards code. Available at: http://www.foodstandards.gov.au (accessed Sep 2005).
- 3. Keogh JB, Clifton PM. The role of meal replacements in obesity treatment. Obes Rev 2005; 6: 229-234.
- 4. Anderson JW, Luan J, Hoie LH. Structured weight-loss programs: meta-analysis of weight loss at 24 weeks and assessment of effects of intervention intensity. Adv Ther 2004; 21: 61-75.
- 5. Heymsfield SB, van Mierlo CA, van der Knaap HC, et al. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 2003; 27: 537-549.
- 6. Ditschuneit HH, Flechtner-Mors M. Value of structured meals for weight management: risk factors and long-term weight maintenance. Obes Res 2001; 9 Suppl 4: S284 S-S289.
- 7. Noakes M, Foster PR, Keogh JB, Clifton PM. Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome. J Nutr 2004; 134: 1894.
- 8. Quinn Rothacker D. Five-year self-management of weight using meal replacements: comparison with matched controls in rural Wisconsin. Nutrition 2000; 16: 344-348.
- 9. Li Z, Hong K, Saltsman P, et al. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 2005; 59: 411-418.
- 10. Hensrud DD. Dietary treatment and long-term weight loss and maintenance in type 2 diabetes. Obes Res 2001; 9 Suppl 4: S348-S353.
- 11. Winick C, Rothacker DQ, Norman RL. Four worksite weight loss programs with high-stress occupations using a meal replacement product. Occup Med (Lond) 2002; 52: 25-30.
- 12. Ashley JM, St Jeor ST, Perumean-Chaney S, et al. Meal replacements in weight intervention. Obes Res 2001; 9 Suppl 4: S312-S320.
- 13. Rothacker DQ, Watemberg S. Short-term hunger intensity changes following ingestion of a meal replacement bar for weight control. Int J Food Sci Nutr 2004; 55: 223-226.
- 14. Huerta S, Li Z, Li HC, et al. Feasibility of a partial meal replacement plan for weight loss in low-income patients. Int J Obes Relat Metab Disord 2004; 28: 1575-1579.
- 15. Hill JO. Obesity treatment: does one size fit all? Am J Clin Nutr 2005; 81: 1253-1254.
I have used several meal replacement products in clinical settings. I am not employed by, and do not receive benefit from, any companies producing these products.